Element Capital Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Element Capital Management’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-68,643	Closed	-$354K	–	1055
2018 Q1	$354K	Buy	+68,643	New	+$488K	0.01%	412
2017 Q4	–	Sell	-12,379	Closed	-$21K	–	179
2017 Q3	$21K	Sell	12,379 -207,252	-94%	-$380K	0.01%	64
2017 Q2	$439K	Buy	+219,631	New	+$429K	0.09%	41

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Intellectus Partners San Francisco, California $578M AUM 49.48% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Element Capital Management's SRNE Position: Q2 2018 in Review

Element Capital Management sold out of Sorrento Therapeutics, Inc. (SRNE) in Q2 2018, closing a stake of 68,643 shares — an estimated $354K sold.

Element Capital Management first reported a position in SRNE in Q2 2017 and held it in 3 quarters. The position peaked at $439K in Q2 2017. 94 funds tracked by Wall St. Rank hold SRNE as of Q2 2018.

Element Capital Management reported no remaining Sorrento Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
Element Capital Management sold 68,643 Sorrento Therapeutics, Inc. shares in Q2 2018, an estimated $354K.
Element Capital Management first reported a position in Sorrento Therapeutics, Inc. in Q2 2017 and held it in 3 quarters.
Element Capital Management's Sorrento Therapeutics, Inc. position peaked at $439K in Q2 2017.
94 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q2 2018.

Based on Element Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.